Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT02207504 · COMPLETED
Trial details
- NCT number
- NCT02207504
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2018-02-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.